[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO993151L - Fremgangsmåte for fremstilling av renset dimer av benavledet faktor - Google Patents

Fremgangsmåte for fremstilling av renset dimer av benavledet faktor

Info

Publication number
NO993151L
NO993151L NO993151A NO993151A NO993151L NO 993151 L NO993151 L NO 993151L NO 993151 A NO993151 A NO 993151A NO 993151 A NO993151 A NO 993151A NO 993151 L NO993151 L NO 993151L
Authority
NO
Norway
Prior art keywords
dimer
derived factor
subjecting
bone
preparation
Prior art date
Application number
NO993151A
Other languages
English (en)
Other versions
NO993151D0 (no
Inventor
Hidetoshi Andou
Jun Honda
Shunjiro Sugimoto
Original Assignee
Hoechst Marion Roussel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18445882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO993151(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Marion Roussel Ltd filed Critical Hoechst Marion Roussel Ltd
Publication of NO993151L publication Critical patent/NO993151L/no
Publication of NO993151D0 publication Critical patent/NO993151D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Fremgangsmåte for fremstilling av en renset dimer av en benavledet faktor, som omfatter underkastelse av et inklusjonslegeme av en benavledet faktor fremstilt ved hjelp av genetisk konstruksjon for følgende trinn a) til. e) i rekkefølge; a) trinnet med behandling av et inklusjonslegeme av en benavledet faktor med et denaturerende middel for å fremstille en oppløst monomer; b) trinnet med behandling av den oppløste monomer med en refoldende oppløsning for å fremstille en dimer; c) trinnet med underkastelse av den refoldende dimer for ultrafiltrering og utbytting av oppløsningsmiddel; d) trinnet med underkastelse av dimeroppløsningen fremstilt ovenfor for isoelektrisk utfelling; og e) trinnet med underkastelse av den isoelektrisk utfelte dimer for revers-fasekromatografi.
NO993151A 1996-12-25 1999-06-24 FremgangsmÕte for fremstilling av renset dimer av benavledet faktor NO993151D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35581296 1996-12-25
PCT/JP1997/004784 WO1998029559A1 (fr) 1996-12-25 1997-12-24 Procede de preparation de dimeres purifies a partir de facteur derive de l'os

Publications (2)

Publication Number Publication Date
NO993151L true NO993151L (no) 1999-06-24
NO993151D0 NO993151D0 (no) 1999-06-24

Family

ID=18445882

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993151A NO993151D0 (no) 1996-12-25 1999-06-24 FremgangsmÕte for fremstilling av renset dimer av benavledet faktor

Country Status (21)

Country Link
US (1) US6551801B1 (no)
EP (1) EP0949335B2 (no)
KR (1) KR20000062328A (no)
AP (1) AP9901539A0 (no)
AT (1) ATE266095T1 (no)
AU (1) AU5339598A (no)
BR (1) BR9714183A (no)
CA (1) CA2275464A1 (no)
DE (1) DE69728997T3 (no)
DK (1) DK0949335T4 (no)
EA (1) EA199900596A1 (no)
ES (1) ES2216181T5 (no)
HU (1) HUP0002573A2 (no)
IL (1) IL130641A0 (no)
NO (1) NO993151D0 (no)
PL (1) PL334303A1 (no)
PT (1) PT949335E (no)
SI (1) SI0949335T2 (no)
TR (1) TR199901479T2 (no)
WO (1) WO1998029559A1 (no)
ZA (1) ZA9711580B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7811793B2 (en) * 1996-12-25 2010-10-12 Biopharma Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Process for preparing purified active monomer of bone-derived factor
US20040019185A1 (en) * 1996-12-25 2004-01-29 Hidetoshi Andou Process for preparing purified active monomer of bone-derived factor
WO2001075095A1 (fr) * 2000-03-30 2001-10-11 Takeda Chemical Industries, Ltd. Procede de production de proteine de recombinaison
AU2003209071B2 (en) * 2002-02-08 2008-08-14 The University Of Erlangen-Nuremberg Formulation comprising bioactive agents and method of using same
CN1735426A (zh) 2002-08-13 2006-02-15 惠氏公司 用作转化生长因子β蛋白质的溶解赋形剂的肽
JP4800739B2 (ja) * 2005-10-20 2011-10-26 デンカ生研株式会社 アッセイ用媒体及びアッセイ方法
CL2007002615A1 (es) * 2006-09-08 2008-04-18 Wyeth Corp Metodos para aislar o purificar un producto que comprende poner el producto enlazado en contacto con al menos una solucion de lavado que comprende arginina y luego eluir el producto; y dicho producto.
AU2007234612B2 (en) * 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
CA2695697A1 (en) 2007-08-07 2009-02-12 Advanced Technologies And Regenerative Medicine, Llc Protein formulations comprising gdf-5 in aqueous acidic solution
WO2009129101A1 (en) * 2008-04-14 2009-10-22 Advanced Technologies And Regenerative Medicine, Llc Liquid buffered gdf-5 formulations
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341610C (en) * 1988-04-08 2011-02-01 Creative Biomolecules, Inc. Osteogenic polypeptides
ATE287949T1 (de) * 1992-07-31 2005-02-15 Stryker Corp Löslicher komplex morphogener proteine und zusammensetzungen davon
JP3570558B2 (ja) * 1993-05-01 2004-09-29 持田製薬株式会社 Dna断片およびそれを含むベクター、該ベクターによって形質転換された形質転換体、該ベクターを用いる蛋白質の産生方法
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
US5399677A (en) * 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
CA2216741C (en) * 1995-04-19 2008-01-15 Hoechst Pharmaceuticals & Chemicals K.K. A novel protein and process for preparing the same
US5702637A (en) * 1995-04-19 1997-12-30 Minnesota Mining And Manufacturing Company Liquid crystal compounds having a chiral fluorinated terminal portion

Also Published As

Publication number Publication date
ES2216181T5 (es) 2009-03-01
TR199901479T2 (xx) 1999-09-21
DE69728997D1 (de) 2004-06-09
US6551801B1 (en) 2003-04-22
AU5339598A (en) 1998-07-31
EP0949335B1 (en) 2004-05-06
SI0949335T2 (sl) 2009-04-30
DK0949335T3 (da) 2004-08-30
NO993151D0 (no) 1999-06-24
ATE266095T1 (de) 2004-05-15
PT949335E (pt) 2004-09-30
DE69728997T2 (de) 2004-09-02
EP0949335A4 (en) 2003-01-22
KR20000062328A (ko) 2000-10-25
EP0949335A1 (en) 1999-10-13
EA199900596A1 (ru) 2000-02-28
EP0949335B2 (en) 2008-11-19
CA2275464A1 (en) 1998-07-09
IL130641A0 (en) 2000-06-01
BR9714183A (pt) 2000-02-29
ES2216181T3 (es) 2004-10-16
HUP0002573A2 (hu) 2000-12-28
DE69728997T3 (de) 2009-07-09
PL334303A1 (en) 2000-02-14
AP9901539A0 (en) 1999-06-30
ZA9711580B (en) 1999-09-23
DK0949335T4 (da) 2009-03-23
SI0949335T1 (en) 2004-10-31
WO1998029559A1 (fr) 1998-07-09

Similar Documents

Publication Publication Date Title
NO993151L (no) Fremgangsmåte for fremstilling av renset dimer av benavledet faktor
PT83205B (pt) Metodo de purificacao e activacao de proteinas a partir de corpos de inclusao insoluveis
DK0775150T3 (da) Fremgangsmåde til reduktion eller fjernelse af endotoksiner
DE69328519D1 (de) Chondroitinase, Herstellungsverfahren und pharmazeutische Zusammensetzung
ATE403671T1 (de) Methoden zur aufreinigung von rekombinatem humanem erythropoietin aus zellkulturüberständen
NO912418L (no) Fremgangsmaate for behandling av blaerecancerceller
UA26375A1 (uk) Спосіб очищеhhя іhсуліhу
CY1107514T1 (el) Μια μεθοδος για την εκχυλιση, καθαρισμο και ενζυματικη τροποποιηση της α’ υπομοναδας σογια 7s σφαιρινης για να χρησιμοποιηθει ως παραγων που προκαλει υποχολεστepολαιμια
DK573587D0 (da) Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion
KR900702011A (ko) 제 x ⅲ 인자의 정제
NZ333712A (en) Method of refolding proteins using a dithiol compound a catalyst and a test to determine the potential use of compounds as protein refolding catalyst
KR910000176A (ko) 맥관 형성 저해제
DE3878577D1 (de) Verwendung von funktionellen polymerharzen als stationaere phase in der affinitaetschromatographie fuer die reinigung des wachstumsfaktors und entsprechendes reinigungsverfahren.
ATE294807T1 (de) Kugelförmige molekülgruppierung
ITUD930003A0 (it) Procedimento per il recupero della sericina disciolta nei bagni di sgommatura, impianto per realizzare tale procedimento e sericina cosi' ottenuta
ATE323760T1 (de) Verfahren zur herstellung eines eine hyaluronidase enthaltenden präparats
Judy et al. Photochemical cross-linking of type I collagen with hydrophobic and hydrophilic 1, 8-naphthalimide dyes
IT1163772B (it) Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche
AU3823195A (en) Process for recovering citric acid
McDermott et al. Purification of a 43 000 Dalton aggregate generated from α-crystallin
YU28799A (en) Process for preparing purified dimer of bone-derived factor
SU763361A1 (ru) Способ регулировани процесса очистки от примесей возвратного растворител
KR960031596A (ko) 신규의 혈전용해효소 및 이의 정제 방법
RU96124332A (ru) Ареактогенный иммуноглобулин для внутривенного введения и способ его получения
DE59808587D1 (de) Verfahren zum Erhöhen der Festigkeit eines porösen Körpers

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application